Italian association for the study of the liver position statement on SARS-CoV2 vaccination

Russo, Francesco Paolo; Piano, Salvatore; Bruno, Raffaele; Burra, Patrizia; Puoti, Massimo; Masarone, Mario; Montagnese, Sara; Ponziani, Francesca Romana; Petta, Salvatore; Aghemo, Alessio

doi:10.1016/j.dld.2021.03.013

Cited by 14 publications

(22 citation statements)

References 43 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A position paper from the Italian Association for the Study of the Liver (AISF) supported priority vaccination for transplant recipients, ultimately placed in Category 1 on the basis of increased risk for severe illness with COVID‐19. In some cases, caregivers were also able to be vaccinated 47 …”

Section: Global Vaccine Equitymentioning

confidence: 99%

Ethical review of COVID-19 vaccination requirements for transplant center staff and patients

Kates

Stock

Ison

et al. 2022

American Journal of Transplantation

Self Cite

View full text Add to dashboard Cite

Transplant centers seeking to increase coronavirus disease 2019 (COVID‐19) vaccine coverage may consider requiring vaccination for healthcare workers or for candidates. The authors summarize current data to inform an ethical analysis of the harms, benefits, and individual and societal impact of mandatory vaccination, concluding that vaccine requirements for healthcare workers and transplant candidates are ethically justified by beneficence, net utility, and fiduciary duty to patients and public health. Implementation strategies should mitigate concerns about respect for autonomy and transparency for both groups. We clarify how the same arguments might be applied to related questions of caregiver vaccination, allocation of other healthcare resources, and mandates for non‐COVID‐19 vaccines. Finally, we call for effort to achieve global equity in vaccination as soon as possible.

show abstract

Section: Global Vaccine Equitymentioning

confidence: 99%

Ethical review of COVID-19 vaccination requirements for transplant center staff and patients

Kates

Stock

Ison

et al. 2022

American Journal of Transplantation

Self Cite

View full text Add to dashboard Cite

show abstract

“…We feel that these positive results strongly emphasise how adequate counselling may enhance vaccination uptake and adherence to the recommendations provided by EASL and by national scientific societies. 1,[9][10][11] A structured program may support rapid and complete COVID-19 vaccination for liver transplant recipients, protecting this frail population.…”

Section: To the Editormentioning

confidence: 99%

High acceptance rate of COVID-19 vaccination in liver transplant recipients

Giannini

Marenco

2021

Journal of Hepatology

View full text Add to dashboard Cite

“…At the beginning of the COVID-19 pandemic, LT recipients were strongly advised to follow all normal preventative measures, including social distancing and the correct use of masks. COVID-19 vaccination is also strongly recommended for LT recipients by the Italian (AISF) [8], European (EASL) [9], and American (AASLD) [10] liver associations. The aim of our study was to assess COVID-19 vaccination hesitancy among LT patients.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Vaccine Acceptance among Liver Transplant Recipients

et al. 2021

View full text Add to dashboard Cite

(1) Background: COVID-19 vaccination hesitancy is a threat for fragile patients. We aimed to evaluate COVID-19 vaccination hesitancy and its reasons in a population of liver transplant (LT) recipients. (2) Methods: In February 2021, a questionnaire on COVID-19 vaccines was sent to LT patients followed at our liver transplant outpatient clinic in Milan, Italy. Sociodemographic and clinical characteristics were recorded. Patients were defined as willing, hesitant, or refusing and their reasons were investigated. Associations between baseline characteristics and willingness were evaluated. Since March 2021, when the COVID-19 vaccines became available for LT candidates and recipients in Italy, the entire cohort of LT recipients was contacted by phone and called for vaccination, and the rate of refusals recorded. (3) Results: The web-based survey was sent to 583 patients, of whom 190 responded (response rate of 32.6%). Among the respondents to the specific question about hesitancy (184), 157 (85.3%) were willing to be vaccinated against COVID-19, while 27 (14.7%) were hesitant. Among the hesitant, three were totally refusing, for a refusal rate of 1.6%. Thirteen hesitant patients (48.1%) answered that their COVID-19 vaccination hesitancy was influenced by being a transplant recipient. The fear of adverse effects was the main reason for refusal (81.5%). Of the 711 LT patients followed at our center, 668 got fully vaccinated, while 43 (6.1%) of them refused the scheduled vaccination. (4) Conclusions: Most patients accepted COVID-19 vaccines, although 6.1% refused the vaccine. Since it is crucial to achieve adequate vaccination of LT patients, it is very important to identify the reasons influencing COVID-19 vaccination hesitancy so that appropriate and targeted communication strategies can be established and specific vaccination campaigns further implemented.

show abstract

Italian association for the study of the liver position statement on SARS-CoV2 vaccination

Cited by 14 publications

References 43 publications

Ethical review of COVID-19 vaccination requirements for transplant center staff and patients

Ethical review of COVID-19 vaccination requirements for transplant center staff and patients

High acceptance rate of COVID-19 vaccination in liver transplant recipients

COVID-19 Vaccine Acceptance among Liver Transplant Recipients

Contact Info

Product

Resources

About